{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:41:47Z","timestamp":1791013307105,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1955,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007077","name":"National Institute of Biomedical Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/mt.2011.27","type":"journal-article","created":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T14:20:08Z","timestamp":1302618008000},"page":"1017-1024","source":"Crossref","is-referenced-by-count":60,"title":["Therapeutic Potential of Intracerebroventricular Replacement of Modified Human \u03b2-Hexosaminidase B for GM2 Gangliosidosis"],"prefix":"10.1016","volume":"19","author":[{"given":"Kazuhiko","family":"Matsuoka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomi","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Dohzono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kitakaze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Sakuraba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.27_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0925-4439(99)00074-5","article-title":"Biochemical consequences of mutations causing the GM2 gangliosidoses","volume":"1455","author":"Mahuran","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2011.27_bib2","series-title":"The Metabolic and Molecular Bases of Inherited Diseases","first-page":"3827","article-title":"The GM2 gangliosidosis","author":"Gravel","year":"2001"},{"key":"10.1038\/mt.2011.27_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1182\/blood.V97.1.327","article-title":"Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation","volume":"97","author":"Jeyakumar","year":"2001","journal-title":"Blood"},{"key":"10.1038\/mt.2011.27_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/GIM.0b013e3181a1b5c5","article-title":"Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment","volume":"11","author":"Shapiro","year":"2009","journal-title":"Genet Med"},{"key":"10.1038\/mt.2011.27_bib5","doi-asserted-by":"crossref","first-page":"10373","DOI":"10.1073\/pnas.0603765103","article-title":"Effective gene therapy in an authentic model of Tay-Sachs-related diseases","volume":"103","author":"Cach\u00f3n-Gonz\u00e1lez","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.27_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/nm1548","article-title":"Stem cells act through multiple mechanisms to benefit mice with neurodegenerative metabolic disease","volume":"13","author":"Lee","year":"2007","journal-title":"Nat Med"},{"key":"10.1038\/mt.2011.27_bib7","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199105233242104","article-title":"Replacement therapy for inherited enzyme deficiency\u2013macrophage-targeted glucocerebrosidase for Gaucher's disease","volume":"324","author":"Barton","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2011.27_bib8","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1097\/GIM.0b013e31818e2c19","article-title":"Dose-response relationships for enzyme replacement therapy with imiglucerase\/alglucerase in patients with Gaucher disease type 1","volume":"11","author":"Grabowski","year":"2009","journal-title":"Genet Med"},{"key":"10.1038\/mt.2011.27_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJM200107053450102","article-title":"Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry's disease","volume":"345","author":"Eng","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2011.27_bib10","first-page":"132","article-title":"Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: results of a phase I\/II clinical trial","volume":"3","author":"Amalfitano","year":"2001","journal-title":"Genet Med"},{"key":"10.1038\/mt.2011.27_bib11","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","article-title":"Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease","volume":"68","author":"Kishnani","year":"2007","journal-title":"Neurology"},{"key":"10.1038\/mt.2011.27_bib12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1542\/peds.2007-3847","article-title":"Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I","volume":"123","author":"Clarke","year":"2009","journal-title":"Pediatrics"},{"key":"10.1038\/mt.2011.27_bib13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2008","journal-title":"Eur J Pediatr"},{"key":"10.1038\/mt.2011.27_bib14","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.27_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.expneurol.2008.10.021","article-title":"Intracerebroventricular infusion of acid sphingomyelinase corrects CNS manifestations in a mouse model of Niemann-Pick A disease","volume":"215","author":"Dodge","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1038\/mt.2011.27_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ymgme.2004.07.003","article-title":"Intrathecal enzyme replacement therapy reduces lysosomal storage in the brain and meninges of the canine model of MPS I","volume":"83","author":"Kakkis","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1038\/mt.2011.27_bib17","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/nbt.1484","article-title":"Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment","volume":"26","author":"Wang","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2011.27_bib18","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1021\/bi0029200","article-title":"Identification of the 6-sulfate binding site unique to alpha-subunit-containing isozymes of human beta-hexosaminidase","volume":"40","author":"Sharma","year":"2001","journal-title":"Biochemistry"},{"key":"10.1038\/mt.2011.27_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0925-4439(02)00221-1","article-title":"A single site in human beta-hexosaminidase A binds both 6-sulfate-groups on hexosamines and the sialic acid moiety of GM2 ganglioside","volume":"1637","author":"Sharma","year":"2003","journal-title":"Biochim Biophys Acta"},{"key":"10.1038\/mt.2011.27_bib20","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.bbrc.2004.09.159","article-title":"An alpha-subunit loop structure is required for GM2 activator protein binding by beta-hexosaminidase A","volume":"324","author":"Zarghooni","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/mt.2011.27_bib21","doi-asserted-by":"crossref","first-page":"10039","DOI":"10.1016\/S0021-9258(19)50196-X","article-title":"Analysis of the glycosylation and phosphorylation of the alpha-subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-directed mutagenesis","volume":"267","author":"Weitz","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1038\/mt.2011.27_bib22","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1093\/glycob\/cwp080","article-title":"Production of human beta-hexosaminidase A with highly phosphorylated N-glycans by the overexpression of the Ogataea minuta MNN4 gene","volume":"19","author":"Akeboshi","year":"2009","journal-title":"Glycobiology"},{"key":"10.1038\/mt.2011.27_bib23","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1111\/j.1523-1755.2004.00924.x","article-title":"Enzyme therapy for Fabry disease: neutralizing antibodies toward agalsidase alpha and beta","volume":"66","author":"Linthorst","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2011.27_bib24","first-page":"2868","article-title":"Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis I","volume":"118","author":"Dickson","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.27_bib25","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1006\/jmbi.1994.1334","article-title":"Satisfying hydrogen bonding potential in proteins","volume":"238","author":"McDonald","year":"1994","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2011.27_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-2836(71)90324-X","article-title":"The interpretation of protein structures: estimation of static accessibility","volume":"55","author":"Lee","year":"1971","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2011.27_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0022-2836(03)00216-X","article-title":"Crystal structure of human beta-hexosaminidase B: understanding the molecular basis of Sandhoff and Tay-Sachs disease","volume":"327","author":"Mark","year":"2003","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2011.27_bib28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J Mol Biol"},{"key":"10.1038\/mt.2011.27_bib29","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/jcc.540160702","article-title":"Accurate modeling of the intramolecular electrostatic energy of proteins","volume":"16","author":"Dudek","year":"1995","journal-title":"J Comput Chem"},{"key":"10.1038\/mt.2011.27_bib30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1063\/1.474409","article-title":"Reaction field methods for off-center multipoles","volume":"107","author":"Kong","year":"1997","journal-title":"J Chem Phys"},{"key":"10.1038\/mt.2011.27_bib31","doi-asserted-by":"crossref","first-page":"9725","DOI":"10.1021\/jp982255t","article-title":"Analysis and application of potential energy smoothing and search methods for global optimization","volume":"B102","author":"Pappu","year":"1998","journal-title":"J Phys Chem"},{"key":"10.1038\/mt.2011.27_bib32","doi-asserted-by":"crossref","first-page":"5933","DOI":"10.1021\/jp027815+","article-title":"Polarizable atomic multipole water model for molecular mechanics simulation","volume":"B107","author":"Ren","year":"2003","journal-title":"J Phys Chem"},{"key":"10.1038\/mt.2011.27_bib33","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1248\/bpb.29.1564","article-title":"Inefficiency in GM2 ganglioside elimination by human lysosomal beta-hexosaminidase beta-subunit gene transfer to fibroblastic cell line derived from Sandhoff disease model mice","volume":"29","author":"Itakura","year":"2006","journal-title":"Biol Pharm Bull"},{"key":"10.1038\/mt.2011.27_bib34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cca.2006.10.010","article-title":"Therapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies","volume":"378","author":"Tsuji","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1038\/mt.2011.27_bib35","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0076-6879(87)38063-2","article-title":"Enzymatic diagnosis of sphingolipidosis","author":"Suzuki","year":"1987"},{"key":"10.1038\/mt.2011.27_bib36","series-title":"Sphingolipid Biochemistry","author":"Hakomori","year":"1983"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616319050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616319050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T03:29:07Z","timestamp":1657682947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616319050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1525001616319050"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.27","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}